Home Tags Gilead Sciences

Tag: Gilead Sciences

Can A Similar Series of Events Expected At Gilead Sciences, Inc....

Gilead Sciences, Inc. (NASDAQ:GILD) enjoyed a weak run from the open in trading on 12/13/2018 with decreased volume coming into the shares and a...

Gilead Sciences, Inc. (GILD) Needs to Cool Off Before It’s Buy-Worthy

Gilead Sciences, Inc. (NASDAQ:GILD) is on recovery track with 6.02% gain from a 1-year low price of $64.27. The company added 0.62% to attain...

A Bit Overly Ripe For Owning: PayPal Holdings, Inc. (PYPL), Gilead...

PayPal Holdings, Inc. (NASDAQ:PYPL) popped in on a low volume green day. Volume on 11-Dec-18 came in at 8.07 million contracts. The daily trading...

96 Institutional Investors Started Taking Positions In Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) is at least 5.01% than its current record low price of $64.27. There was a -0.97% decline on 12/10/2018 that...

Should Value Investors Pick AGNC Investment Corp. (AGNC), Gilead Sciences, Inc....

AGNC Investment Corp. (NASDAQ:AGNC) has a price-to-sales ratio of 3.71, well below its REIT - Residential competitors. For the industry, the average P/S ratio...

2 Stocks Taking a Gut Shot: R.R. Donnelley & Sons Company...

R.R. Donnelley & Sons Company (NYSE:RRD) popped in on a low volume red day. Volume on 06-Dec-18 came in at 0.99 million contracts. The...

Get to Know Why Newmark Group, Inc. (NMRK) And Gilead Sciences,...

Newmark Group, Inc. (NASDAQ:NMRK) recently saw its volume around 17.05 million shares and on average it trades 606.04 million shares a day. The opening...

Can These Stocks Continue To Spark? – R.R. Donnelley & Sons...

R.R. Donnelley & Sons Company (NYSE:RRD) popped in on a low volume red day. Volume on 04-Dec-18 came in at 0.7 million contracts. The...

Gilead Sciences, Inc. (NASDAQ:GILD)’s Institutional Ownership In The September Quarter

Gilead Sciences, Inc. (NASDAQ:GILD) recovered 10.25% of its value since hitting low of $64.27. The recent move of -1.5% drop pushed the stock to...

Whether You Like Or Hate Gilead Sciences, Inc. (GILD) And Express,...

Fundamentally, Gilead Sciences, Inc. (NASDAQ:GILD) looks appealing. Its stock trades at 3.92 times the company’s sales over the past 12 months. The broad Biotechnology...